Nicotinamide Adénine Dinucléotide in food supplements
53 supplements declared in France contain Nicotinamide Adénine Dinucléotide as a substance or active ingredient.
Other names in the Compl'Alim list: NAD+.
Compl'Alim declarations. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
In plain words
À quoi il sert, selon les fabricants
Objectives most often stated for supplements that contain it (Nicotinamide Adénine Dinucléotide): antioxydant (18 produits), cheveux et ongles (4 produits), digestion (4 produits), immunité (4 produits), peau (4 produits).
These are the objectives manufacturers declared to the authorities, not proven effects. On the packaging, only health claims authorised by the EU may be written.
Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Nouvel aliment ou pas
Consommé avant le 15 mai 1997, mais seulement dans des compléments alimentaires : il peut y être utilisé ; dans un autre aliment, il lui faudrait une autorisation.
The Commission's catalogue is indicative: it does not replace a decision.
Novel Food Catalogue (status of products under Regulation (EU) 2015/2283), retrieved 21 October 2026.
Declared daily quantities
| Unit | Products | Median | Minimum | Maximum |
|---|---|---|---|---|
| mg | 51 | 300 | 0.01 | 1,500 |
Calculated from Compl'Alim declarations that provide a quantity. These are quantities declared by manufacturers, not measurements, and preparation is not distinguished (powder, extract of varying concentration): differences between products can be very large.
What the registers say, country by country
Each line repeats what an official register says on the date it was consulted. Not being in a register means neither allowed nor banned.
Novel food catalogue (European Union), entry “Nicotinamide adenine dinucleotide ”: Consommé avant le 15 mai 1997, mais seulement dans des compléments alimentaires : il peut y être utilisé ; dans un autre aliment, il lui faudrait une autorisation.
POL-NF-09841. Novel Food Catalogue (status of products under Regulation (EU) 2015/2283), retrieved 21 October 2026.
Compl'Alim ingredient list (France): listed.
Compl'Alim, reference list of ingredients, retrieved 21 October 2026.
Canada, licensed natural health products (LNHPD): 1 product.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
United States, supplement labels (DSLD; supplements need no prior approval): 39 products.
Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Poland, notified supplements: 26 products.
GIS, products notified in Poland, retrieved 27 October 2026.
Główny Inspektorat Sanitarny (GIS), Rejestr produktów objętych powiadomieniem
What we know about this ingredient
A molecule found naturally in plants or organisms; in a supplement it may be extracted from them, made by fermentation or synthesised: the declaration does not say which.
Basis: one CosIngThe European Commission's database of cosmetic ingredients. CAS and natural occurrence recorded in Wikidata (LOTUS database).
Wikidata: names of substances in six languages and taxa in which they occur (largely from the LOTUS database), retrieved 23 October 2026.
Natural occurrence recorded in Wikidata (LOTUS database): 2 taxa; examples: Caenorhabditis elegans, Homo sapiens.
Wikidata: names of substances in six languages and taxa in which they occur (largely from the LOTUS database), retrieved 23 October 2026.
Associated research
ClinicalTrials.gov · A trial is not proof: it tests a hypothesis.
- NCT07692633 : A Clinical Trial to Assess the Absorption, Safety, and Efficacy of an Oral Nicotinamide Adenine Dinucleotide (NAD+) Supplement in Healthy Adults
NOT_YET_RECRUITING · NA · NAD+ Bioavailability, NAD+ Safety, NAD+ Efficacy · 2026-08-11 · NAD+
- NCT07839130 : PEDIatric Cardiac Dysfunction Treated With Injectable Nicotinamide Adenine Dinucleotide
NOT_YET_RECRUITING · PHASE2 · Cardiac Dysfunction · 2026-09-24 · Nicotinamide Adenine Dinucleotide; Nicotinamide Adenine Dinucleotide (synonym declared in the registry)
- NCT06919328 : Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+
RECRUITING · NA · Healthy Aging · 2025-04-09 · NAD+
Searched on 1 November 2026.
Scientific publications (PubMed)
11,510 records published in the five years before 12 November 2026. The name is searched in the title or abstract; derivatives and passing mentions can be counted. This count does not measure effectiveness.
Searched on 12 November 2026.
Most recent systematic reviews and meta-analyses:
- PMID 42952324. Energetic metabolism in bipolar disorder: from markers to precision therapeutics. (2026, Acta neuropsychiatrica)
- PMID 42877680. NAD(+) signaling in Parkinson's disease: molecular mechanisms and therapeutic perspectives. (2026, Frontiers in neurology)
- PMID 42774067. Domain-specific effects of NAD(+) precursors on fatigue and functional performance: a systematic review and network meta-analysis. (2026, Frontiers in nutrition)
Other names: Nicotinamidadenindinukleotid (German), nicotinamida adenina dinucleótido (Spanish), nicotinammide adenina dinucleotide (Italian), dinucleótido de nicotinamida e adenina (Portuguese).
Wikidata: names of substances in six languages and taxa in which they occur (largely from the LOTUS database), retrieved 23 October 2026.
Same substance in cosmetics: NICOTINAMIDE ADENINE DINUCLEOTIDE.
Products
Other related records
- NAD+ w/ Resveratrol Lipo Gel Supplement from the US market
- Liposomal NAD+ Supplement from the US market
- T-Bomb 3xtreme Supplement from the US market
- Clinical Strength T-Bomb 3xtreme Supplement from the US market
- RipFire Xcelerate : étiquette retirée du marché américain Supplement from the US market